It has been confirmed by a recent study that the Covid-19 mortality in kidney transplant recipients or KTR was much higher than the general population. The news is that the number is very low in Chennai city and comorbidities and timely intervention could prevent the Covid-19 deaths. This has been mentioned by some local doctors.
It is worthy to note that this study was conducted across 13 kidney transplant centres in India between the months of March and September 2020. It was pointed out that the access to healthcare was low in the above period and this could have led to Covid-19 deaths. The study would be published in the magazine ‘Transplantation’ and it showed that the mortality rate in KTR patients infected with Covid-19 was higher than the general public.
Chief Nephrologist, Dr. R. Balasubramaniam of Kauvery hospitals was of the view that in the initial stages there were fewer patients due to the lockdown and there was less access to the hospitals. He added that the patients were scared to go to the hospitals and it led to delayed intervention. These could have resulted in the complications. Truth is that regulation of medication is an important factor in preventing mortality and the timing and follow-up adherence is also important in treatment.